Skip to main content

VNDA

Stock
Health Care
Biotechnology

Performance overview

VNDA Price
Price Chart

Forward-looking statistics

Beta
0.94
Risk
51.56%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

Company info

SectorHealth Care
IndustryBiotechnology
Employees274
Market cap$356.2M

Fundamentals

Enterprise value-$51.0M
Revenue$201.4M
Revenue per employee—
Profit margin-21.98%
Debt to equity2.30

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.76
Dividend per share—
Revenue per share$3.45
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio—

Macro factor sensitivity

Growth-0.2
Credit+5.3
Liquidity-0.2
Inflation-2.2
Commodities+0.2
Interest Rates-2.0

Valuation

Dividend yield0.00%
PEG Ratio24.85
Price to sales1.45
P/E Ratio24.85
Enterprise Value to Revenue-0.25
Price to book0.57

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend day—

News

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates

Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.07 per share a year ago.

Zacks Investment Research (May 7, 2025)
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

HC Wainwright initiated coverage on Vanda Pharmaceuticals, Inc. VNDA, a commercial-stage biopharmaceutical firm primarily focusing on neurological and neuropsychiatry disorders.

Benzinga (November 1, 2024)
Vanda Insights: Aramco share sale is not surprising

Vandana Hari, founder of Vanda Insights, says it'll be a "test of investor appetite."

CNBC International TV (May 31, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free